4D Molecular Therapeutics reported total assets of $492.62M and total liabilities of $84.96M for the quarter ended Jun 2026, up 4.0% year over year. This balance sheet covers 27 quarters of results from Dec 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||||
| Current Assets | |||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 90.99M | 153.00M | 75.97M | 113.48M | 108.30M | 52.35M | 78.57M | 236.31M | 275.68M | 249.11M | 275.59M | 189.06M | 187.54M | 149.34M | 133.53M | 77.16M | 48.55M | 60.24M | 72.49M | 70.37M | |||||||
| Short-term InvestmentsInvestments (Current) | 70.69M | 94.78M | 160.18M | 127.60M | 119.42M | 161.20M | 121.89M | 74.03M | 43.99M | 39.12M | 250.32M | 352.88M | 314.35M | 275.54M | 187.91M | 216.07M | 256.51M | 342.41M | 318.40M | 290.96M | |||||||
| Cash & Current Investments | 161.68M | 247.78M | 236.15M | 241.09M | 227.72M | 213.55M | 200.45M | 310.34M | 319.66M | 288.23M | 525.91M | 541.95M | 501.89M | 424.88M | 321.44M | 293.23M | 305.06M | 402.65M | 390.89M | 361.33M | |||||||
| Receivables - NetNet Receivables | 0.80M | 0.05M | |||||||||||||||||||||||||
| Receivables - OtherOther Receivables | 0.70M | 0.70M | |||||||||||||||||||||||||
| Receivables | 0.80M | 0.75M | 0.70M | ||||||||||||||||||||||||
| Prepaid Assets | 3.27M | 8.46M | 6.89M | 5.43M | 4.76M | 6.96M | 6.59M | 7.43M | 8.58M | 8.36M | 9.68M | 10.69M | 8.87M | 10.05M | 11.13M | 10.06M | 7.31M | 10.48M | 14.47M | 17.01M | |||||||
| Current Assets | 165.73M | 256.28M | 243.05M | 246.52M | 232.48M | 220.51M | 207.04M | 317.78M | 328.24M | 296.59M | 535.59M | 552.63M | 510.76M | 434.93M | 332.57M | 303.29M | 312.38M | 413.13M | 405.36M | 382.96M | |||||||
| Non-Current Assets | |||||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 8.79M | 14.39M | 18.46M | 21.10M | 22.05M | 22.26M | 21.61M | 21.30M | 20.74M | 20.13M | 19.46M | 18.76M | 19.87M | 19.53M | 18.75M | 17.50M | 16.15M | 14.87M | 13.59M | 12.38M | |||||||
| Long-Term Investments | 65.49M | 67.65M | 48.36M | 20.53M | 11.12M | 4.91M | 1.41M | 10.95M | 62.94M | 35.72M | 48.78M | 80.58M | 137.00M | 123.81M | 67.17M | 111.38M | 66.74M | 69.30M | |||||||||
| Other Non-Current Assets | 0.60M | 0.60M | 0.88M | 0.96M | 1.05M | 1.08M | 1.26M | 1.08M | 0.68M | 0.68M | 0.77M | 2.32M | 2.86M | 4.26M | 7.04M | 9.39M | 9.38M | 9.19M | 9.86M | 11.44M | |||||||
| Non-Current Assets | 74.89M | 97.21M | 81.88M | 56.41M | 47.69M | 41.34M | 36.98M | 34.73M | 33.37M | 43.30M | 94.30M | 67.48M | 93.27M | 125.45M | 183.16M | 170.35M | 111.61M | 153.58M | 107.54M | 109.66M | |||||||
| Assets | 240.62M | 353.49M | 324.93M | 302.94M | 280.16M | 261.85M | 244.02M | 352.50M | 361.61M | 339.89M | 629.88M | 620.12M | 604.03M | 560.38M | 515.73M | 473.64M | 423.98M | 566.71M | 512.90M | 492.62M | |||||||
| Liabilities | |||||||||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||||||||
| Accounts Payables | 3.71M | 4.76M | 2.68M | 3.32M | 1.48M | 3.32M | 2.41M | 3.49M | 4.71M | 3.52M | 4.22M | 3.43M | 2.92M | 4.39M | 4.15M | 8.70M | 6.86M | 11.16M | 14.69M | 12.52M | |||||||
| Payables | 3.71M | 4.76M | 2.68M | 3.32M | 1.48M | 3.32M | 2.41M | 3.49M | 4.71M | 3.52M | 4.22M | 3.43M | 2.92M | 4.39M | 4.15M | 8.70M | 6.86M | 11.16M | 14.69M | 12.52M | |||||||
| Accumulated Expenses | 5.93M | 7.74M | 5.26M | 6.16M | 7.24M | 8.87M | 5.41M | 6.58M | 10.19M | 12.01M | 9.01M | 12.78M | 21.41M | 18.87M | 16.20M | 19.19M | 24.19M | 26.87M | 22.87M | 25.43M | |||||||
| Other Accumulated Expenses | 0.42M | 1.77M | 0.21M | 0.75M | 0.19M | 0.38M | 0.04M | 0.05M | 0.16M | 0.10M | 0.14M | 0.10M | 0.12M | 0.11M | 0.16M | 0.10M | 0.11M | 0.13M | 0.20M | 0.12M | |||||||
| Current Leases | 1.23M | 2.04M | 2.60M | 2.63M | 2.65M | 2.68M | 3.10M | 3.13M | 3.15M | 3.17M | 3.20M | 5.09M | 5.64M | 5.68M | 5.72M | 5.70M | 5.59M | 5.49M | 5.37M | ||||||||
| Current Deferred Revenue | 4.74M | 5.09M | 3.87M | 3.71M | 3.21M | 1.96M | 1.66M | 1.42M | 1.23M | 0.27M | 1.32M | 1.32M | 1.31M | 0.26M | 0.87M | 1.07M | 0.36M | 0.36M | 0.36M | 0.36M | |||||||
| Total Current Liabilities | 11.37M | 16.34M | 12.09M | 14.33M | 13.56M | 15.73M | 11.28M | 13.75M | 18.16M | 18.95M | 16.40M | 19.40M | 29.46M | 29.15M | 26.90M | 34.68M | 37.11M | 43.98M | 43.40M | 47.67M | |||||||
| Non-Current Liabilities | |||||||||||||||||||||||||||
| Non-Current Debt | 19.59M | ||||||||||||||||||||||||||
| Non-Current Deffered Revenue | 3.01M | 2.49M | 1.76M | 1.45M | 1.00M | 1.08M | 0.88M | 0.85M | 1.10M | 0.97M | 1.32M | 1.32M | 1.28M | 1.06M | 0.43M | 0.22M | 0.83M | 0.74M | 2.12M | 2.96M | |||||||
| Preferred Stock Liabilities | |||||||||||||||||||||||||||
| Operating Leases | 15.22M | 14.78M | 14.40M | 13.92M | 13.47M | 13.01M | 12.53M | 12.03M | 11.52M | 11.00M | 10.46M | 19.74M | 18.97M | 18.17M | 17.36M | 16.57M | 15.82M | 15.05M | 14.26M | ||||||||
| Other Non-Current Liabilities | 1.89M | 0.21M | 0.22M | 0.22M | 0.21M | 0.21M | 0.22M | 0.21M | 0.37M | 0.37M | 0.37M | 0.38M | 0.40M | 0.41M | 0.32M | 0.33M | 0.34M | 0.36M | 0.37M | 0.38M | |||||||
| Total Non-Current Liabilities | 14.60M | 34.17M | 28.65M | 30.20M | 28.51M | 30.30M | 25.20M | 27.15M | 31.31M | 31.69M | 28.95M | 31.39M | 50.68M | 49.37M | 45.68M | 52.41M | 54.65M | 60.69M | 60.70M | 84.57M | |||||||
| Total Liabilities | 16.48M | 34.38M | 28.87M | 30.42M | 28.72M | 30.51M | 25.41M | 27.36M | 31.68M | 32.06M | 29.32M | 31.78M | 51.08M | 49.78M | 46.01M | 52.75M | 55.00M | 61.05M | 61.07M | 84.96M | |||||||
| Shareholder's Equity | |||||||||||||||||||||||||||
| Total Debt | 19.59M | ||||||||||||||||||||||||||
| Common Equity | 224.13M | 319.11M | 296.06M | 272.52M | 251.44M | 231.34M | 218.61M | 325.14M | 329.93M | 307.83M | 600.56M | 588.34M | 552.95M | 510.61M | 469.72M | 420.89M | 368.98M | 505.66M | 451.84M | 407.66M | |||||||
| Liabilities and Shareholders Equity | 240.62M | 353.49M | 324.93M | 302.94M | 280.16M | 261.85M | 244.02M | 352.50M | 361.61M | 339.89M | 629.88M | 620.12M | 604.03M | 560.38M | 515.73M | 473.64M | 423.98M | 566.71M | 512.90M | 492.62M | |||||||
| Retained Earnings | -181.91M | -207.00M | -233.33M | -261.42M | -287.11M | -314.49M | -343.20M | -372.80M | -383.04M | -415.33M | -447.73M | -482.70M | -526.52M | -576.20M | -624.20M | -678.83M | -735.70M | -716.30M | -785.10M | -858.00M | |||||||
| Treasury Shares |